Similar articles

• PUVA-induced suppression of contact sensitivity to mustine hydrochloride in mycosis fungoides.

  Volden G, Molin L, Thomsen K. Volden G, et al. Br Med J. 1978 Sep 23;2(6141):865-6. doi: 10.1136/bmj.2.6141.865. Br Med J. 1978. PMID: 152137 Free PMC article. No abstract available.
• [Contact urticaria and anaphylactic reactions induced by topical application of nitrogen mustard].

  Sánchez Yus E, Surárez Martín E. Sánchez Yus E, et al. Actas Dermosifiliogr. 1977 Jan-Feb;68(12):39-44. Actas Dermosifiliogr. 1977. PMID: 140594 Spanish. No abstract available.
• A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.

  Estève E, Bagot M, Joly P, Souteyrand P, Beylot-Barry M, Vaillant L, Delaunay M, Avril MF, Laroche L, Grange F, Thomine E, Wechsler J. Estève E, et al. Arch Dermatol. 1999 Nov;135(11):1349-53. doi: 10.1001/archderm.135.11.1349. Arch Dermatol. 1999. PMID: 10566833
• Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides.

  Vonderheid EC. Vonderheid EC. Int J Dermatol. 1984 Apr;23(3):180-6. doi: 10.1111/j.1365-4362.1984.tb04507.x. Int J Dermatol. 1984. PMID: 6373639 Review. No abstract available.
• Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data.

  Liner K, Brown C, McGirt LY. Liner K, et al. Drug Des Devel Ther. 2018 Jan 31;12:241-254. doi: 10.2147/DDDT.S137106. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29440874 Free PMC article. Review.